Real‐World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome

Background Management of patients with non–ST‐segment–elevation acute coronary syndrome (NSTE‐ACS) is based on 2020 European Society of Cardiology guidelines, which recommend the preferential use of prasugrel over ticagrelor. Because the selection of the respective P2Y12 inhibitor has to consider la...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mustafa Yildirim, Matthias Mueller‐Hennessen, Barbara Ruth Milles, Moritz Biener, Hauke Hund, Norbert Frey, Evangelos Giannitsis, Christian Salbach
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-08-01
coleção:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	acute coronary syndrome eligibility label use prasugrel ticagrelor
Acesso em linha:	https://www.ahajournals.org/doi/10.1161/JAHA.123.030879
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!